(Q50062264)

English

New insights into sorafenib resistance in hepatocellular carcinoma: Responsible mechanisms and promising strategies.

scientific article published on 17 October 2017

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/29054475

New insights into sorafenib resistance in hepatocellular carcinoma: Responsible mechanisms and promising strategies. (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/29054475

fibrolamellar hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

author name string

Leilei Niu

1

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/29054475

Liping Liu

2

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/29054475

Shengli Yang

3

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/29054475

Jianwei Ren

4

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/29054475

Paul B S Lai

5

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/29054475

George G Chen

6

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/29054475

publication date

17 October 2017

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/29054475

Biochimica et Biophysica Acta

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/29054475

1868

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/29054475

2

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/29054475

564-570

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/29054475

miR‑222 regulates sorafenib resistance and enhance tumorigenicity in hepatocellular carcinoma

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.3892/IJO.2014.2577

Identifiers

10.1016/J.BBCAN.2017.10.002

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/29054475

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/29054475

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50062264&oldid=2042480837"